Nestlé Health Science Acquires Nuun from TSG Consumer Partners
May 10, 2021
Nestlé Health Science has agreed to acquire Nuun, a Seattle-based hydration supplement brand, from private equity firm TSG Consumer Partners. Financial terms were not disclosed and the transaction was expected to close in the second half of 2021.
- Buyers
- Nestlé Health Science
- Targets
- Nuun
- Sellers
- TSG Consumer Partners
- Industry
- Food & Beverage
- Location
- Washington, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Nestlé Health Science Acquires Majority Stake in Orgain
February 2, 2022
Food & Beverage
Nestlé Health Science has agreed to acquire a majority stake in Orgain, the U.S. plant-based nutrition company, from founder Dr. Andrew Abraham and Butterfly Equity; both sellers will retain minority ownership positions. Dr. Andrew Abraham will remain CEO of Orgain and the deal will let Nestlé Health Science expand its portfolio of clean, plant-based nutrition products globally; the transaction is subject to customary regulatory approvals.
-
Nestlé Health Science Acquires Majority Stake in Vital Proteins
June 10, 2020
Food & Beverage
Nestlé Health Science (NHSc), a subsidiary of Nestlé, agreed to acquire a majority stake in Vital Proteins, the US market leader in collagen-based supplements, beverages and food products. Vital Proteins will continue to operate as a standalone business under CEO Kurt Seidensticker, with the deal intended to accelerate global expansion and product innovation.
-
Sanofi Acquires Qunol
September 29, 2023
Consumer Products
Sanofi has completed the acquisition of Qunol, a U.S.-based vitamins and supplements brand, to strengthen its Consumer Healthcare (CHC) portfolio in the Vitamin, Mineral and Supplements (VMS) category. The deal adds Qunol's CoQ10 and Turmeric offerings—targeting heart and joint health—to Sanofi's U.S. consumer health lineup and supports expansion into the healthy-aging segment.
-
Nestlé Health Science / Société des Produits Nestlé S.A. to acquire Aimmune Therapeutics
August 31, 2020
Pharmaceuticals
Nestlé Health Science (NHSc), via a Nestlé S.A. acquisition subsidiary (Société des Produits Nestlé S.A.), agreed to acquire Aimmune Therapeutics for USD34.50 per share in cash, valuing the company at approximately USD2.6 billion. NHSc already owned ~25.6% of Aimmune; the tender offer is expected to close in Q4 2020 and will expand Nestlé's portfolio with Aimmune's FDA-approved peanut allergy therapy Palforzia.
-
Unilever Acquires Onnit
April 26, 2021
Consumer Products
Unilever has signed an agreement to acquire Onnit, an Austin-based holistic wellness and lifestyle company known for its nootropic supplement Alpha BRAIN and DTC health products. Onnit will remain based in Austin and led by CEO Jason Havey, with founder Aubrey Marcus staying on as a brand ambassador; terms were not disclosed and the deal is subject to customary approvals.
-
Nestlé Acquires The Bountiful Company's Core Vitamin Brands for $5.75B
August 9, 2021
Food & Beverage
Nestlé (via Nestlé Health Science) agreed to acquire the core vitamin and supplement brands of The Bountiful Company from KKR and Carlyle for $5.75 billion, integrating brands such as Nature's Bounty, Solgar, Puritan's Pride and Osteo Bi‑Flex into its NHSc portfolio. The deal (expected/closed in H2 2021) brings roughly 4,000–4,500 employees into Nestlé Health Science and establishes Nestlé as a global leader in vitamins, minerals and nutritional supplements across mass retail, specialty retail and e‑commerce.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.